These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 12381273)

  • 21. Evaluation of immunity status to routine vaccination in pediatric liver transplant candidates.
    Dehghani SM; Shakiba MA; Ziaeyan M; Imanieh MH; Haghighat M; Sedaghat M; Alborzi A; Malek-Hosseini SA
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():26-31. PubMed ID: 25910330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.
    Heijstek MW; van Gageldonk PG; Berbers GA; Wulffraat NM
    Ann Rheum Dis; 2012 Jun; 71(6):948-54. PubMed ID: 22172491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric immunizations.
    Edwards KM
    Curr Probl Pediatr; 1993; 23(5):186-209. PubMed ID: 8354078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody waning after immunosuppressive chemotherapy and immunomodulators, re-immunization considerations in pediatric patients with malignancy and chronic immune thrombocytopenic purpura.
    Abdolkarimi B; Amanati A; Molavi Vardanjani H; Jamshidi S; Tabaeian SAP
    BMC Infect Dis; 2022 Jul; 22(1):657. PubMed ID: 35902837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of immune response following immunization with DTP/Td and MMR vaccines in children treated for acute lymphoblastic leukemia.
    Koochakzadeh L; Khosravi MH; Pourakbari B; Hosseinverdi S; Aghamohammadi A; Rezaei N
    Pediatr Hematol Oncol; 2014 Oct; 31(7):656-63. PubMed ID: 25007393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination coverage rates and attitudes towards mandatory vaccinations among healthcare personnel in tertiary-care hospitals in Greece.
    Maltezou HC; Tseroni M; Drositis I; Gamaletsou MN; Koukou DM; Bolikas E; Peskelidou E; Daflos C; Panagiotaki E; Ledda C; Pavli A; Moussas N; Kontogianni S; Svarna E; Ploumidis M; Spyrou A; Chini M; Adamis G; Lourida A; Hatzigeorgiou D; Gargalianos P; Syrogiannopoulos G; Sipsas NV
    Expert Rev Vaccines; 2022 Jun; 21(6):853-859. PubMed ID: 35382665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody Response against Vaccine Antigens in Children after TCRαβ-Depleted Haploidentical Stem Cell Transplantation: Is It Similar to That in Recipients with Fully Matched Donors?
    Kondolot M; Yilmaz E; Erdog Sahin N; Ozcan A; Kaynar L; Unal E; Karakukcu M
    Transplant Cell Ther; 2023 Feb; 29(2):128.e1-128.e9. PubMed ID: 36323399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of chronic hepatitis B virus infection and immunity to measles, rubella, tetanus and diphtheria among schoolchildren aged 6-7 years old in the Solomon Islands, 2016.
    Breakwell L; Anga J; Cooley G; Ropiti L; Gwyn S; Wannemuehler K; Woodring J; Ogaoga D; Martin D; Patel M; Tohme RA
    Vaccine; 2020 Jun; 38(30):4679-4686. PubMed ID: 32473876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands.
    Tielemans SMAJ; de Melker HE; Hahné SJM; Boef AGC; van der Klis FRM; Sanders EAM; van der Sande MAB; Knol MJ
    BMJ; 2017 Aug; 358():j3862. PubMed ID: 28855159
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients.
    Kawamura K; Yamazaki R; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kimura S; Kikuchi M; Nakasone H; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
    Hematology; 2015 Mar; 20(2):77-82. PubMed ID: 24992512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization in end stage renal disease: The perception of waiting list patients.
    Camargo LF; Lother AM; Mazzali M; Stucchi RSB
    Transpl Infect Dis; 2018 Jun; 20(3):e12831. PubMed ID: 29337400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
    Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
    Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody persistence and booster vaccination of a fully liquid hexavalent vaccine coadministered with measles/mumps/rubella and varicella vaccines at 15-18 months of age in healthy South African infants.
    Madhi SA; Koen A; Cutland C; Groome M; Santos-Lima E
    Pediatr Infect Dis J; 2013 Aug; 32(8):889-97. PubMed ID: 23538523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diphtheria-Tetanus-Polio, Measles-Mumps-Rubella, and Hepatitis B Vaccination Coverage and Associated Factors among Homeless Children in the Paris Region in 2013: Results from the ENFAMS Survey.
    Mansor-Lefebvre S; Le Strat Y; Bernadou A; Vignier N; Guthmann JP; Arnaud A; Lévy-Bruhl D; Vandentorren S
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32326203
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
    MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The control of diphtheria, tetanus, poliomyelitis, measles, rubella and mumps.
    Dudgeon JA
    Practitioner; 1975 Sep; 215(1287):299-309. PubMed ID: 1101251
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with vaccination among inflammatory bowel disease patients in Korea.
    Yun HS; Min YW; Chang DK; Rhee PL; Kim JJ; Rhee JC; Kim YH
    Korean J Gastroenterol; 2013 Apr; 61(4):203-8. PubMed ID: 23624734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children?
    Bardenheier B; Yusuf H; Schwartz B; Gust D; Barker L; Rodewald L
    Arch Pediatr Adolesc Med; 2004 Jun; 158(6):569-75. PubMed ID: 15184221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.